Exelixis Inc (NASDAQ:EXEL)

2.86
Delayed Data
As of May 05
 -0.08 / -2.72%
Today’s Change
1.26
Today|||52-Week Range
4.55
+98.61%
Year-to-Date

Today’s Trading

Previous close2.94
Today’s open2.94
Day’s range2.80 - 2.96
Volume2,597,460
Average volume (3 months)3,769,880
Market cap$576.0M
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+41.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.34+1.83%
LXRXLexicon Pharmaceutic...-0.01-0.96%
FLXNFlexion Therapeutics...+0.52+2.89%
ARWRArrowhead Research C...-0.01-0.14%
Data as of 05/05/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers